Novel Tetrahydroisoquinoline-Based Heterocyclic Compounds Efficiently Inhibit SARS-CoV-2 Infection In Vitro
Sign Up to like & getrecommendations! Published in 2023 at "Viruses"
DOI: 10.3390/v15020502
Abstract: The ongoing COVID-19 pandemic has caused over six million deaths and huge economic burdens worldwide. Antivirals against its causative agent, SARS-CoV-2, are in urgent demand. Previously, we reported that heterocylic compounds, i.e., chloroquine (CQ) and… read more here.
Keywords: vitro; tetrahydroisoquinoline based; based heterocyclic; replication ... See more keywords